Valmont Industries Inc (VMI)

Debt-to-equity ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands 729,941 898,201 1,017,540 1,107,640 1,107,880 977,260 952,704 985,636 870,935 935,129 995,647 963,065 947,072 897,488 860,878 729,589 728,431 779,788 778,283 776,139
Total stockholders’ equity US$ in thousands 1,542,090 1,541,690 1,471,480 1,409,290 1,354,280 1,501,740 1,612,220 1,540,100 1,580,850 1,512,730 1,488,380 1,476,050 1,386,850 1,318,140 1,294,620 1,224,810 1,182,060 1,162,440 1,126,840 1,087,410
Debt-to-equity ratio 0.47 0.58 0.69 0.79 0.82 0.65 0.59 0.64 0.55 0.62 0.67 0.65 0.68 0.68 0.66 0.60 0.62 0.67 0.69 0.71

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $729,941K ÷ $1,542,090K
= 0.47

The debt-to-equity ratio of Valmont Industries Inc has exhibited some fluctuations over the past few years. It decreased from 0.71 as of March 31, 2020, to 0.47 as of December 31, 2024. The trend in the ratio indicates that the company has been reducing its reliance on debt as a source of financing relative to equity.

The ratio dipped to its lowest point of 0.47 as of December 31, 2024, suggesting a strong position in terms of financial leverage and solvency. However, it is important to note the slight increase in the ratio from 0.59 as of June 30, 2023, to 0.82 as of December 31, 2023, which could indicate a temporary increase in debt levels or a decrease in equity during that period.

Overall, the decreasing trend in the debt-to-equity ratio indicates that Valmont Industries Inc has been managing its debt levels efficiently and maintaining a healthy balance between debt and equity in its capital structure.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-equity ratio
Valmont Industries Inc
VMI
0.47
Arcosa Inc
ACA
0.00
Proto Labs Inc
PRLB
0.00